Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors
Journal of Obstetrics and Gynaecology Research · 2023
DOI: 10.1111/jog.15768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Makoto Iizuka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan. Hauptthemen laut MEDLINE: Neoplasms, Glandular and Epithelial, Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Objective
To compare the risk of ovarian malignancy algorithm (ROMA) and Copenhagen Index (CPH‐I) in their ability to distinguish epithelial ovarian cancer (EOC) and malignant ovarian tumors (MLOT) from benign ovarian tumors (BeOT) in Japanese women.
Methods
Patients with pathologically diagnosed ovarian tumors were included in this study. The study validated the diagnostic performance of ROMA and CPH‐I.
Results
Among the 463 Japanese women included in this study, 312 had BeOT, 99 had EOC, and 52 had other MLOT. The receiver‐operator characteristic (ROC) area under the curve (AUCs) of ROMA (0.89) and CPH‐I (0.89) for distinguishing EOC from BeOT were significantly higher than that of CA125 (0.82) (CA 125 vs. ROMA; p = 0.002, vs. CPH‐I; p < 0.001). The ROC‐AUCs of ROMA (0.82) and CPH‐I (0.81) for distinguishing MLOT from BeOT were significantly higher than that of CA125 (0.75) (CA 125 vs. ROMA: p = 0.003, vs. CPH‐I: p < 0.001). The sensitivity (SN)/specificity (SP) of ROMA and CPH‐I for distinguishing EOC from BeOT at standard cut‐off points were 69%/90%, and 69%/90%, respectively, those for distinguishing MLOT from BeOT were 54%/90%, and 55%/90%, respectively.
Conclusion
ROMA and CPH‐I performed comparably well and better than CA125 in distinguishing EOC from BeOT in Japanese women. ROMA and CHP‐I should be used with caution in practical situations, where all histological possibilities for must be considered, because the SNs of ROMA and CPH‐I were only 54% and 55%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
- Center for Genetic Counseling, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
- Department of Pathology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
ORCID-Profile: Yoshinobu Hamada
Zitieren
APA
Iizuka, M., Hamada, Y., Matsushima, J., Ichikawa, T., Irie, T., Yamaguchi, N., Sakamoto, S., Ban, S., & Takakura, S. (2023). Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15768
Vancouver
Iizuka M, Hamada Y, Matsushima J, Ichikawa T, Irie T, Yamaguchi N, et al. Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15768
BibTeX
@article{Iizuka2023,
author = {Iizuka, Makoto and Hamada, Yoshinobu and Matsushima, Jun and Ichikawa, Teppei and Irie, Taichi and Yamaguchi, Noriko and Sakamoto, Shuichi and Ban, Shinichi and Takakura, Satoshi},
title = {Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
doi = {10.1111/jog.15768}
}
EUVIMED